Direct intra-accumbal infusion of a beta-adrenergic receptor antagonist abolishes WIN 55,212-2-induced aversion.
about
Cannabinoid and opioid interactions: implications for opiate dependence and withdrawalCannabinoid modulation of noradrenergic circuits: implications for psychiatric disordersEndocannabinoid signaling in the etiology and treatment of major depressive illness.Repeated administration of a synthetic cannabinoid receptor agonist differentially affects cortical and accumbal neuronal morphology in adolescent and adult ratsAre Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?Nicotine Enhances Footshock- and Lithium Chloride-Conditioned Place Avoidance in Male Rats.
P2860
Direct intra-accumbal infusion of a beta-adrenergic receptor antagonist abolishes WIN 55,212-2-induced aversion.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Direct intra-accumbal infusion ...... WIN 55,212-2-induced aversion.
@en
Direct intra-accumbal infusion ...... WIN 55,212-2-induced aversion.
@nl
type
label
Direct intra-accumbal infusion ...... WIN 55,212-2-induced aversion.
@en
Direct intra-accumbal infusion ...... WIN 55,212-2-induced aversion.
@nl
prefLabel
Direct intra-accumbal infusion ...... WIN 55,212-2-induced aversion.
@en
Direct intra-accumbal infusion ...... WIN 55,212-2-induced aversion.
@nl
P2860
P1433
P1476
Direct intra-accumbal infusion ...... WIN 55,212-2-induced aversion
@en
P2093
Elisabeth J Van Bockstaele
P2860
P356
10.1016/J.NEULET.2011.06.008
P407
P577
2011-06-15T00:00:00Z